English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
News and events

27 June 2017 - A new therapeutic approach to the Becker muscular dypriophy, signed agreement

The signature meeting was held at the Regione Lombardia premises in the afternoon of June 27, 2017.

13 April 2017 - POR FESR 2014-2020: Linea innovazione (Innovation line)

The Italfarmaco's project "ITF-Becker a new therapeutic approach at the Becker Muscular Dystrophy (BMD)"

17 March 2017 - Peripheral occlusive arterial disease (PAD)

European objective of no amputations with early diagnosis and proper prevention; proper therapy could reduce amputations by 70%

02 March 2016 - Market launch of Akynzeo

Market launch of Akynzeo, new NK-1 antagonist serotonergic

30 September 2015 - Acquisition of Effik, S.A.

Italfarmaco Group announces the acquisition of the remaining 50% in Effik, S.A.

29 September 2015 - New Italfarmaco representative office in Vietnam

Opening of the new Group representative Office

31 July 2014 - GMP Approval by Turkish Authorities

Approval of the Italfarmaco manufacturing plant of Milan

30 June 2014 - FDA approves the registration of Enoxaparine

The manufacturing is started at the Italfarmaco manufacturing plant of Milan

11 June 2014 - Inauguration of the new branch office in Moscow

Inauguration of the new Italfarmaco representative office in Moscow

29 November 2013 - New manufacturing plant

Inauguration of the new chemical-pharmaceutical manufacturing plant of ITF Chemical (Bahia-Brasil)